Relapse of BCR-ABL1-like ALL mediated by the ABL1 kinase domain mutation T315I following initial response to dasatinib treatment

D. T. Yeung, D. J. Moulton, S. L. Heatley, E. Nievergall, P. Dang, J. Braley, S. Branford, S. Moore, C. G. Mullighan, T. P. Hughes, D. L. White

Research output: Contribution to journalLetterpeer-review

19 Citations (Scopus)
Original languageEnglish
Pages (from-to)230-232
Number of pages3
Issue number1
Publication statusPublished or Issued - 10 Jan 2015

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this